Welcome to our dedicated page for Dynatronics news (Ticker: DYNT), a resource for investors and traders seeking the latest updates and insights on Dynatronics stock.
Company Overview
Dynatronics Corp (DYNT) is a longstanding, reputable manufacturer, marketer, and distributor of advanced medical devices and rehabilitation equipment. Drawing on over three decades of experience, the company has built a robust reputation for excellence in clinical support and customer service, positioning itself as a reliable and knowledgeable force in the healthcare equipment industry. With a focus on advanced technology and innovative design, Dynatronics serves a broad spectrum of clinical applications including physical therapy, chiropractic, athletic training, and sports medicine.
Core Products and Services
At its core, Dynatronics designs and manufactures a wide range of high-quality medical devices that include treatment tables, rehabilitation equipment, and an extensive selection of over 8,000 products and supplies. The product portfolio is structured to meet the diverse needs of orthopedists, physical therapists, chiropractors, and sports medicine practitioners. Advanced medical technology is intricately woven into every product category, ensuring that customers benefit from reliable, innovative, and clinically supported solutions.
Distribution and Customer Support
The company distinguishes itself through a comprehensive distribution network that includes both a dedicated sales force and an expansive network of active distributors. With a substantial field support team, Dynatronics provides prompt service that encompasses equipment setup and ongoing in-service training, ensuring that clinicians and healthcare providers maximize the functionality and effectiveness of their equipment.
Commitment to Quality and Clinical Expertise
Quality and precision are at the heart of Dynatronics' operations. The company's commitment to competitive pricing is matched by its focus on delivering exceptional clinical support and training. This dual emphasis has allowed Dynatronics to forge strong relationships within the healthcare community, reassuring its customers that each product is backed by industry-leading expertise and technical support.
Industry Position and Market Significance
Within the competitive landscape of the medical device and rehabilitation equipment market, Dynatronics has carved out a niche by combining high-quality product innovation with unparalleled customer service. The company’s strategic emphasis on research, development, and clinical collaboration has allowed it to adapt to evolving needs in the healthcare market without compromising on service or quality. Manufacturers, distributors, and clinical professionals alike appreciate Dynatronics’ comprehensive approach that integrates distribution efficiency with thorough technical support and training.
Operational Excellence and Support Services
Dynatronics has consistently demonstrated operational excellence, underpinned by its experienced sales team and extensive network of distributors. This combination ensures widespread market reach and immediate responsiveness to customer requirements. The company's field service team is well-versed in all aspects of equipment installation, maintenance, and user training, providing an essential service that enhances client confidence and satisfaction.
Closing Insights
Overall, Dynatronics Corp establishes itself as a reliable and proficient entity within the medical device and rehabilitation sectors. Its comprehensive product range, backed by professional clinical support and an efficient distribution network, makes it a pivotal player for healthcare providers seeking quality and reliability in their equipment choices. This detailed overview aims to serve as an evergreen resource, offering deep insights into the company’s operations, business model, and market role without digressing into time-sensitive specifics.
Dynatronics Corporation (NASDAQ:DYNT) announced it will release its financial results for Q1 FY2023 on November 10, 2022, before market open. A conference call will follow at 8:00 AM ET, featuring prepared remarks and a Q&A session with analysts. Participants can dial 888-506-0062 (U.S.) or 973-528-0011 (international) to join, using passcode 844024. An audio replay will be available post-call. The company specializes in medical devices for physical therapy and rehabilitation, marketing products through various established brands.
Dynatronics Corporation (NASDAQ: DYNT) reported financial results for Q4 FY '22, achieving net sales of $11.2 million, a 14% increase year-over-year, alongside a gross profit margin expansion to 23.4%. Despite a net loss of $1.6 million, the company forecasts FY '23 net sales of $45-$48 million, indicating a 5% growth. The CEO highlighted positive market reception to their new business model and anticipated improvements in cash flow as inventory is sold down. However, ongoing inflation, supply chain challenges, and pandemic impacts pose risks.
Dynatronics Corporation (NASDAQ:DYNT) announced it will release its financial results for the fourth quarter and fiscal year ended June 30, 2022, on September 22, 2022, before market opens. Following the results, management will hold a conference call at 8:00 AM ET to discuss the performance, featuring a presentation and a Q&A session. Interested participants can access the call via phone or through the company’s Investor Relations website. The call is expected to provide insights into the company's recent financial metrics and future outlook.
Dynatronics Corporation (NASDAQ:DYNT) announced a senior leadership reorganization aimed at boosting sales growth and profitability. CEO John Krier will also serve as Chief Financial Officer, taking on responsibilities previously held by Norm Roegner, who is departing the company. Mike Withers, with extensive IT experience, is appointed as the new Chief Information Officer, filling a vacancy since 2020. These strategic changes are intended to streamline operations and align IT systems with business goals, enhancing revenue growth for the company.
Dynatronics Corporation (NASDAQ:DYNT) reported its Q3 FY '22 results, highlighting a net sales of $10.3 million and a gross profit margin increase to 22.4%. Despite a net loss of $1.5 million, the company anticipates a 16% sales growth for Q4, projecting total FY '22 sales between $44 million and $45 million, approximately a 20% increase from the previous year. The firm continues to face challenges due to COVID-19 but remains focused on market share expansion and product innovations, targeting gross margins above 40% over time.
Dynatronics Corporation (NASDAQ:DYNT) announces the release of its financial results for the fiscal third quarter ended March 31, 2022, set for May 12, 2022, before market opening. Following the announcement, a conference call will occur at 10:00 AM ET, featuring management remarks, a slide presentation, and a Q&A session with analysts. Participants can join via a dedicated phone line or through a provided webcast link. The event aims to provide insights into the company's performance and strategic outlook for investors.
EAGAN, MN / ACCESSWIRE / March 24, 2022 / Dynatronics Corporation (NASDAQ:DYNT) announced its participation in Maxim Group's 2022 Virtual Growth Conference. The management's on-demand webcast for investors will be available on March 28, 2022, on the company's Investor Relations website. This conference, hosted by M-Vest, runs from March 28-30, 2022, from 9:00 a.m. to 5:00 p.m. EDT. Dynatronics specializes in manufacturing a range of medical devices for physical therapy, rehabilitation, and athletic training, marketing products under well-known brands.
Dynatronics Corporation (NASDAQ:DYNT) announced its participation in two upcoming investor conferences: the Roth Capital Conference on March 14, 2022, and the Maxim Group Virtual Growth Conference on March 28-29, 2022. CEO John Krier will provide updates and engage in one-on-one meetings at these events. A virtual on-demand presentation and a live fireside chat will be available for investors during the Roth event, with archived access on the company's investor webpage. Dynatronics focuses on high-quality restorative products for physical therapy and rehabilitation.
Dynatronics Corporation (NASDAQ:DYNT) reported Q2 FY '22 financial results, achieving total net sales of $10.5 million but incurring a net loss of $1.4 million. The company maintains confidence in its outlook, expecting net sales for FY '22 to range between $40 million and $45 million, up 15% from previous benchmarks. COVID-19 continues to pose challenges, including increased costs and supply chain issues. The focus remains on business transformation, new product launches, and enhancing operational efficiency to drive sustainable growth.
Dynatronics Corporation (NASDAQ:DYNT) will release its fiscal second quarter results for the period ended December 31, 2021, on February 10, 2022, before market opening. A conference call and webcast will follow at 10:00 AM ET that same day, including management's remarks, a slide presentation, and a Q&A session. Access details include dialing 888-506-0062 for U.S./Canada participants or 973-528-0011 for international callers. The live webcast will be available on the company's Investor Relations website, with an archive for future viewing.
FAQ
What is the current stock price of Dynatronics (DYNT)?
What is the market cap of Dynatronics (DYNT)?
What is the primary business of Dynatronics Corp?
Which product categories does Dynatronics offer?
How does Dynatronics ensure customer support?
What distinguishes Dynatronics in the healthcare equipment industry?
Who are the typical customers of Dynatronics?
How does Dynatronics maintain its quality standards?
In which market segments does Dynatronics operate?
How does Dynatronics ensure the efficiency of its distribution network?
